RecruitingNCT05269472

Trigeminal Neuralgia Electrophysiology

Trigeminal Evoked Responses to Improve Rhizotomy


Sponsor

University of Minnesota

Enrollment

30 participants

Start Date

Apr 4, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The study intervention is to perform standard somatosensory evoked responses limited to the face during rhizotomy procedures of the gasserian ganglion (trigeminal ganglion) for the treatment of trigeminal neuralgia. The evoked responses will be measured at two locations before and after the clinical rhizotomy including: the standard contralateral scalp (EEG) and at the gasserian ganglion through an FDA-approved recording electrode.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adults of 18 years or older
  • Scheduled to undergo percutaneous rhizotomy for facial pain
  • Adults of 18 years or older

Exclusion Criteria8

  • Facial pain of unclear origin (i.e. not clearly TGN pain)
  • Rhizotomy procedure canceled
  • Diagnosis or history of facial pain such as TMD or TGN
  • History of migraine
  • History of any functional pain disorder: fibromyalgia, IBS, CRPS
  • Recent chronic pain (within last month)
  • Unwilling to participate for two hours in lab
  • Current acute pain

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETrigeminal Electrophysiology

This study will pilot and test the feasibility of introducing electrophysiology into the routine rhizotomy procedure by including trigeminal somatosensory evoked potentials (TSEPs) and recording from electrodes at the level of the ganglion.


Locations(1)

University of Minnesota

Minneapolis, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05269472


Related Trials